speb/financial-data huggingface dataset:
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 3262700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — EBIT: 4636000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — EBITDA: 5711900000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 17346000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 176200000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 176200000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -374000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Income: 3262700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 3262700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 3636700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 3262700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 3262700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 3636700000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -176200000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -176200000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 5535400000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 3118624424.86
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Operating Income: 4257600000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 23925000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 201900000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 6551600000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Other Special Charges: -176500000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 4459800000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 6579000000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1075900000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 176500000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 32424424.86
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 819300000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 19667400000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 176500000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 176500000.00
IPCALAB.NS income_statement (quarterly, 2025-12-31) — Write Off: 0.00
IPCALAB.NS income_statement (annual, 2026-03-31) — +Operating Expense: 49521200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 13201300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — +Total Revenue: 95625400000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 23884800000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 9402900000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 9402900000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 20142600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 20142600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -28921500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -28921500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 967800000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -119900000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -119900000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Amortization: 180700000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 180700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 32500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 32500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 399000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 399000000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 253664122.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 11.79
IPCALAB.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 9246300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 15602200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 15602200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -6559500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: 0.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 1048200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1048200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 4371200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4371200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11955800000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11955800000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -524100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 2506500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 2506500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 1864700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 1864700000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1705800000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -606700000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 478000000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Change In Payable: 667700000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -489100000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -2939500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 1416800000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 253700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 80638100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 80638100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 8303000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 8303000000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 29802200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 6916200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Assets: 63768600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 63768600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 179300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 179300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Debt: 5948200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 5948200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 6127500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6127500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 587800000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 587800000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 23069300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 23069300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 1583000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 1583000000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Depreciation: 4000500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 4181200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 4181200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1071400000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 4000500000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 1071400000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 253664122.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 11.79
IPCALAB.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 11411200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2990700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 24300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 24300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — EBIT: 16482500000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — EBIT: 4246500000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — EBITDA: 20663700000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — EBITDA: 5317900000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — End Cash Position: 10663000000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -7535200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 10883500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 10883500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 4860200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 16900000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of Business: -653500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -2714600000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1396400000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Goodwill: 828100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 828100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1975800000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1975800000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 20262500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 20262500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 81630400000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 81630400000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Gross Profit: 65823200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 16968600000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 77700000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Interest Expense: 757300000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 202000000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 757300000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 202000000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Interest Income: 317200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 317200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -815800000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 314600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Inventory: 27310000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 27310000000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 87677500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 87677500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -2467700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 399200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 399200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Investmentsin Associatesat Cost: -319600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Associatesat Cost: -319600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Investmentsin Joint Venturesat Cost: 2155700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Joint Venturesat Cost: 2155700000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 3199500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 3199500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 868900000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 868900000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1091200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1091200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1960100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1960100000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 0.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -5252200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 1836100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1836100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 979100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 979100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 51917300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 51917300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 14602500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 14602500000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Minority Interests: -426600000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Minority Interests: -76200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: 0.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2668200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2668200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 488200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Income: 11411200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Income: 2990700000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 11411200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2990700000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 11837800000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 3066900000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 11411200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2990700000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 11411200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2990700000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 15725200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 11837800000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 3066900000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Interest Income: -473700000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -202000000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 553100000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -6029800000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -5252200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -473700000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -202000000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -10000000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 3389600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Net PPE: 52708900000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 52708900000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -6559500000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -777600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 78662300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 78662300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Accrued Expenses: 0.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 0.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 0.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 205400000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 205400000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2448600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 2448600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 2549700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 2549700000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 20699900000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5776100000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Normalized Income: 11438625784.09
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 3341218185.19
IPCALAB.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 11419700000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Operating Income: 16302000000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Operating Income: 3767300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Operating Revenue: 95625400000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 23884800000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 253704218.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: -100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 57700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 57700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 874600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 874600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: -239900000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: -239900000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1147700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1147700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 884200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 884200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 1024600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 700000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 700000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 4200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 4200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 137100000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 937400000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 11220000000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 6799900000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Payable: 4339500000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 4339500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2608400000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2608400000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 762600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 762600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 7584600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 7584600000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Other Special Charges: 267000000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Other Special Charges: 458200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Payables: 14343000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Payables: 14343000000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 1810000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1810000000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Pretax Income: 15725200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 4044500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 40100000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: 0.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: 0.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -6559500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 11126100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 11126100000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 29802200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 6916200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 4181200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1071400000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 179300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 179300000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -5252200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Research And Development: 1167000000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 24300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 24300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 66285000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 66285000000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 553100000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 9277000000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 10673400000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Share Issued: 253704218.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 253704218.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Special Income Charges: -645000000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: -458200000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 8100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 80638100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 80638100000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 78662300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 78662300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -8774215.91
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -107681814.81
IPCALAB.NS income_statement (annual, 2026-03-31) — Tax Provision: 3811500000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 950500000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.24
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 1673100000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1673100000.00
IPCALAB.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -4139500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Assets: 123701900000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 123701900000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 81729300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 81729300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Debt: 8087600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 8087600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 95240600000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 95240600000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Total Expenses: 79323400000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 20117500000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 28461300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 28461300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 59933300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 59933300000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5392000000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 5392000000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 33600000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 576300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 576300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -36200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: -458200000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -36200000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -458200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Tradeand Other Payables Non Current: 4200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 4200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Work In Process: 4416200000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 4416200000.00
IPCALAB.NS balance_sheet (annual, 2026-03-31) — Working Capital: 40699300000.00
IPCALAB.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 40699300000.00
IPCALAB.NS income_statement (annual, 2026-03-31) — Write Off: 300300000.00
IPCALAB.NS income_statement (quarterly, 2026-03-31) — Write Off: 0.00
IPCO.TO cash_flow (annual, 2021-12-31) — Change In Other Current Assets: -36115000.00
IPCO.TO cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
IPCO.TO balance_sheet (annual, 2021-12-31) — Net Debt: 92215000.00
IPCO.TO cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -872000.00
IPCO.TO cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
IPCO.TO balance_sheet (annual, 2021-12-31) — Treasury Shares Number: 1160651.00
IPCO.TO income_statement (annual, 2022-12-31) — +Operating Expense: 25198000.00
IPCO.TO income_statement (annual, 2022-12-31) — +Total Revenue: 1241814000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 20547000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 112696000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -1278279000.00
IPCO.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 146662032.00
IPCO.TO income_statement (annual, 2022-12-31) — Basic EPS: 2.30
IPCO.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 18810000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1217000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -157813000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 1259000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 338719000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 487240000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 487240000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 487240000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -13305000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Changes In Cash: 455115000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Common Stock: 338719000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: 0.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 965140000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Common Stock Payments: -80578000.00
IPCO.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 725105000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Current Assets: 638566000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 752000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Current Debt: 3431000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 4183000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 149905000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 8048000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Deferred Tax: 127413000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Depreciation: 134436000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 134436000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
IPCO.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 149976365.00
IPCO.TO income_statement (annual, 2022-12-31) — Diluted EPS: 2.25
IPCO.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 337683000.00
IPCO.TO income_statement (annual, 2022-12-31) — EBIT: 485827000.00
IPCO.TO income_statement (annual, 2022-12-31) — EBITDA: 620263000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 13315000.00
IPCO.TO cash_flow (annual, 2022-12-31) — End Cash Position: 487240000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Financial Assets: 0.00
IPCO.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 11110000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: 444005000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 0.00
IPCO.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 14440000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 5243000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 2271481000.00
IPCO.TO income_statement (annual, 2022-12-31) — Gross Profit: 516709000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 11741000.00
IPCO.TO income_statement (annual, 2022-12-31) — Interest Expense: 20689000.00
IPCO.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 20689000.00
IPCO.TO income_statement (annual, 2022-12-31) — Interest Income: 6966000.00
IPCO.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 6966000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -11445000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Interest Received Cfo: 6656000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Inventory: 15958000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 1272722000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -157813000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Investment Properties: 4764000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 35882000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 300000000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 507000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Long Term Debt: 304151000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 304658000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 300000000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -100979000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 203389000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 204853000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Minority Interest: 191000.00
IPCO.TO income_statement (annual, 2022-12-31) — Minority Interests: -42000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 0.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -80578000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: 7872000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Income: 337683000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 337683000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 337725000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 337683000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 337683000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 337725000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 337725000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Interest Income: -18501000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 199021000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 199021000.00
IPCO.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -18501000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -101750000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Net PPE: 993202000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -157813000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 959897000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1960000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 56334000.00
IPCO.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: 620263000.00
IPCO.TO income_statement (annual, 2022-12-31) — Normalized Income: 337683000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: 601818000.00
IPCO.TO income_statement (annual, 2022-12-31) — Operating Income: 491511000.00
IPCO.TO income_statement (annual, 2022-12-31) — Operating Revenue: 1241814000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 136827999.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Other Equity Interest: 11349000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 28942000.00
IPCO.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: 10758000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Other Payable: 19973000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Other Properties: 2065411000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Other Receivables: 10913000.00
IPCO.TO income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Payables: 58313000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Pension And Employee Benefit Expense: 542000.00
IPCO.TO income_statement (annual, 2022-12-31) — Pretax Income: 465138000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Properties: 0.00
IPCO.TO cash_flow (annual, 2022-12-31) — Purchase Of Business: 0.00
IPCO.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -157813000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 15958000.00
IPCO.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 725105000.00
IPCO.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 134436000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: -100979000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -80578000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Restricted Cash: 4000000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: 635895000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 0.00
IPCO.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 14440000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Share Issued: 136827999.00
IPCO.TO income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
IPCO.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 7997000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 965140000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 959897000.00
IPCO.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
IPCO.TO income_statement (annual, 2022-12-31) — Tax Provision: 127413000.00
IPCO.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.27
IPCO.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 18000.00
IPCO.TO cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -16470000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Assets: 1679617000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 1269291000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Debt: 308841000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 965331000.00
IPCO.TO income_statement (annual, 2022-12-31) — Total Expenses: 750303000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 714286000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1041051000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 564381000.00
IPCO.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 4778000.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Total Tax Payable: 17793000.00
IPCO.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
IPCO.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 0.00
IPCO.TO balance_sheet (annual, 2022-12-31) — Working Capital: 488661000.00
IPCO.TO income_statement (annual, 2023-12-31) — +Operating Expense: 31863000.00
IPCO.TO income_statement (annual, 2023-12-31) — +Total Revenue: 960203000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 42761000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 97264000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1403867000.00
IPCO.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 132080662.00
IPCO.TO income_statement (annual, 2023-12-31) — Basic EPS: 1.31
IPCO.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 487240000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 2814000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -313239000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 2896000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 243361000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 517074000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 517074000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -31000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 517074000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: 36058000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 31250000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Common Stock: 243361000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -31000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1080074000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Common Stock Payments: -95358000.00
IPCO.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 709689000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Current Assets: 690597000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 809000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Current Debt: 3589000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 4398000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 202888000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 8097000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 55362000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Depreciation: 111303000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 111303000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 263000.00
IPCO.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 135349211.00
IPCO.TO income_statement (annual, 2023-12-31) — Diluted EPS: 1.28
IPCO.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 172951000.00
IPCO.TO income_statement (annual, 2023-12-31) — EBIT: 253976000.00
IPCO.TO income_statement (annual, 2023-12-31) — EBITDA: 365279000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1416000.00
IPCO.TO cash_flow (annual, 2023-12-31) — End Cash Position: 517074000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Financial Assets: 7049000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 37563000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: 32915000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -19018000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -19018000.00
IPCO.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 18455000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 15352000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 2710541000.00
IPCO.TO income_statement (annual, 2023-12-31) — Gross Profit: 250514000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 35504000.00
IPCO.TO income_statement (annual, 2023-12-31) — Interest Expense: 25635000.00
IPCO.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 25635000.00
IPCO.TO income_statement (annual, 2023-12-31) — Interest Income: 21774000.00
IPCO.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 21774000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -21977000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Interest Received Cfo: 20884000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Inventory: 21808000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 1524146000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -352467000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Investment Properties: 0.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 41486000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 137550000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2087000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 440483000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 442570000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 137550000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3111000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 250657000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 204853000.00
IPCO.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 185000.00
IPCO.TO income_statement (annual, 2023-12-31) — Minority Interests: -28000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -59419000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -95358000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: 1911000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Income: 172951000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 172951000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 172979000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 172951000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 172951000.00
IPCO.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 172979000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 172979000.00
IPCO.TO income_statement (annual, 2023-12-31) — Net Interest Income: -7417000.00